Role of the hexosamine biosynthetic pathway in diabetic nephropathy
about
Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismHigh prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular diseaseDistinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its ComplicationsHyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsAssociation analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.Glucosamine-induced OGT activation mediates glucose production through cleaved Notch1 and FoxO1, which coordinately contributed to the regulation of maintenance of self-renewal in mouse embryonic stem cells.Emerging roles of the myocardin family of proteins in lipid and glucose metabolism.Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelExpression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathyTNF-α and microalbuminuria in patients with type 2 diabetes mellitus.A little sugar goes a long way: the cell biology of O-GlcNAc.Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1.Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.Topiramate Protects Pericytes from Glucotoxicity: Role for Mitochondrial CA VA in Cerebromicrovascular Disease in Diabetes.Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancerA glimpse of various pathogenetic mechanisms of diabetic nephropathy.High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes.Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats.Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.Absence of renal enlargement in fructose-fed proximal-tubule-select insulin receptor (IR), insulin-like-growth factor receptor (IGF1R) double knockout mice.Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.Hyaluronan matrices in pathobiological processes.Pathophysiology of the diabetic kidney.Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells.Regulation of Cellular Metabolism and Hypoxia by p53.Effect of spent turmeric on kidney glycoconjugates in streptozotocin-induced diabetic rats.Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.
P2860
Q21284705-E4B981B8-1E00-4216-B891-590A210ABEFDQ24679632-55007B49-F1C1-4D34-86C6-5A252AE60378Q24813839-204EE95F-8C30-48F3-9109-7FA8C82F01DCQ26752842-9BF6F9B2-B759-4A66-A381-E202A5BC5222Q26773988-AD46CDAE-0323-4F9C-A91D-1EC583007F5CQ26783344-3B124451-FB6C-452F-9A79-EB10EF0D28EBQ27014620-8C68CFE7-5620-42FE-81DF-37A2E3E11689Q28086840-61F2B584-F6CB-4F71-B9DC-BA194DEAB1C9Q33547739-F263A577-FCF9-4ADD-BCC5-06B39172A47FQ33554440-A0F9B0B5-47AF-45E5-BB0A-2B2D06FB4751Q33683197-55DBCAA9-8090-41EE-BE44-F05AF0AF0357Q33849720-99E5003B-37B9-4DF3-8B98-532471AEA72BQ34082034-EA60BB26-700A-4DA0-8081-13E74C329239Q34521411-A86AA73B-BF92-4D75-8504-26F6B9DDF266Q34535062-EF4842D0-7D3D-4F18-A472-E95EFA440262Q34653233-C4156E54-3BBE-47D8-B0A0-76CABCEFC216Q34744328-DE9FA1DE-6EEB-4713-B8E3-C2F2E818C56CQ34838338-4894E20A-8BED-4CAA-8BEE-E9321942D9CEQ35261648-038BE3E2-B48E-4C27-B681-172473E165B0Q35312586-E677F50D-F63F-4594-AF83-BDF66508D752Q35713992-65A68DC9-28F5-4F4D-A6B2-FE752D7734A5Q35831554-31BBB26B-7F12-404F-8389-5CD39F728C1EQ36263001-128481AA-B535-452D-A51D-0C956A03E33EQ36409564-2A4CD1B7-A28A-4283-B259-62E343C744B4Q36426843-3170220B-A35D-4493-AAF2-202A6743453AQ36919879-6B5B7903-381A-4CD9-BCCB-89001FD63FB4Q36979205-E85C5097-19D5-42AB-99ED-03DFB1F31385Q37419575-2208F72E-B69E-4BD0-8CB2-3A99EA650F7BQ37437526-4C14D311-8A93-451C-82AA-7F6853C6BC98Q37484328-5A6EDC5A-3D09-4F1B-801C-B6148FE26F7EQ37691659-5475A61D-7D9B-41E4-B194-B205ADEF5705Q37710679-58E7E2A1-1C0D-4B40-B3E8-84DD5B02B803Q37746309-F94241AE-B2C2-43A4-BA55-7CDAFE60D245Q37848478-DBCF12A8-9528-46B9-9C59-1FF004B70501Q38111707-5BF0CCFA-1697-4DFF-81D9-312031DA46CFQ38463463-4CF20882-9FBE-40B4-AAD7-EDF6C66F11C8Q38782030-2814492D-7A8C-47A8-A91D-7A3F98F540FBQ38884003-641308CF-CF7D-452D-B777-D56BB7695CC5Q41897225-2C512420-5219-47FD-8F6F-1C5548771E62Q42019593-7CAB876B-2D51-4C7A-92C6-E1B603566391
P2860
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@ast
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@en
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@nl
type
label
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@ast
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@en
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@nl
prefLabel
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@ast
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@en
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@nl
P3181
P1476
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
@en
P2093
E D Schleicher
P3181
P407
P577
2000-09-01T00:00:00Z